[HTML][HTML] Ten-year Time-trend Analysis of Dyslipidemia Among Adults in Wuhan
M Zhang, Z Wan, Y Lv, Y Huang, L Hu, H Xu… - Current Medical …, 2022 - Springer
Objective Dyslipidemia is associated with an increased risk of cardiovascular disease, the
major cause of death in an aging population. This study aimed to estimate the prevalence of …
major cause of death in an aging population. This study aimed to estimate the prevalence of …
[PDF][PDF] Serum lipid levels and the prevalence of dyslipidaemia among rural and urban Thai adults-Are the NCEP III guidelines appropriate?
A Patel, M Woodward, R Stolk… - Journal-Medical …, 2005 - thaiscience.info
The authors' objective was to describe the distribution of serum lipids and the prevalence of
dyslipidaemia using US lipid-lowering guidelines in an adult Thai population. Fasting serum …
dyslipidaemia using US lipid-lowering guidelines in an adult Thai population. Fasting serum …
The prevalence, awareness, and treatment of lipid abnormalities in Iranian adults: Surveillance of risk factors of noncommunicable diseases in Iran 2016
Background Hypercholesterolemia is one of the modifiable risk factors for atherosclerosis
and cardiovascular diseases. Prevention and treatment of hypercholesterolemia and other …
and cardiovascular diseases. Prevention and treatment of hypercholesterolemia and other …
Prevalence, treatment and control of dyslipidaemia in Switzerland: still a long way to go
M Firmann, P Marques-Vidal, F Paccaud… - European Journal of …, 2010 - academic.oup.com
Background There is little information regarding the prevalence and management of
dyslipidaemia in Switzerland. Design Cross-sectional population-based study of 3238 …
dyslipidaemia in Switzerland. Design Cross-sectional population-based study of 3238 …
[HTML][HTML] Public perceptions and knowledge of cholesterol management in a multi-ethnic Asian population: A population-based survey
Introduction Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide.
Hyperlipidemia is one of the important modifiable risk factors for CVDs. Raising public …
Hyperlipidemia is one of the important modifiable risk factors for CVDs. Raising public …
Investigation on status of dyslipidemia in Chinese females aged 35 years or above
MY Ma, XL Chen, Z Chen, X Wang… - Zhonghua xin xue …, 2022 - europepmc.org
Objective: To investigate the prevalence, awareness, treatment and control status of
dyslipidemia among females aged≥ 35 years old across China. Methods: Participants were …
dyslipidemia among females aged≥ 35 years old across China. Methods: Participants were …
[PDF][PDF] Hypercholesterolemia prevalence, awareness, treatment and control among adults in Malaysia: the 2015 National Health and Morbidity Survey, Malaysia
HM Rifin, TGR Lourdes, NL Ab Majid… - Glob. J. Health …, 2018 - academia.edu
Abstract Background & Objective: Dyslipidaemia is one of the main modifiable risk factors for
cardiovascular disease (CVD). Therefore, it is crucial to examine the prevalence …
cardiovascular disease (CVD). Therefore, it is crucial to examine the prevalence …
Relationship between dyslipidemia and diabetes mellitus among adult residents in Jiangsu province
R TAO, J ZHOU, J SU - Chinese Journal of Public Health, 2015 - zgggws.com
ObjectiveTo explore the relationship between dyslipidemia and diabetes mellitus in adult
residents of Jiangsu province, and to provide a scientific basis for formulating strategies and …
residents of Jiangsu province, and to provide a scientific basis for formulating strategies and …
[HTML][HTML] Dyslipidemia in primary care–prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)
E Steinhagen-Thiessen, P Bramlage, C Lösch… - Cardiovascular …, 2008 - Springer
Background Current guidelines from the European Society of Cardiology (ESC) define low
thresholds for the diagnosis of dyslipidemia using total cholesterol (TC) and LDL-cholesterol …
thresholds for the diagnosis of dyslipidemia using total cholesterol (TC) and LDL-cholesterol …